戻る Agenda
Live Oral Poster Presentations II
Learning Objective : NOTE: Abstract co-authored by lauren.pilling@roche.com & victor.gitman@roche.com To explore strategies that effectively anticipate and meet the developing safety needs of patients and healthcare professionals by delivering transparent and contextualised safety information at scale.
Speaker(s)
Putting safety at the forefront of patient experiences
Lauren Pilling
F. Hoffmann-La Roche Ltd, Switzerland
Senior PV Process Director
Digital Health: A boon or burden to PV? Analysis of the macroenvironment and forces challenging this opportunity
James Whitehead, MBA, MSC
Visiting Lecturer - Pharmacovigilance MSc Course, University of Hertfordshire, United Kingdom
Former Senior Director Device & Digital Safety - AstraZeneca
Clinical Utility Score for Prioritisation (CUSP), a Method to Identify High-Utility Safety Reports: A Prospective Assessment
Christopher Golds
GSK, United Kingdom
Safety Process Lead
CTR Benefits and Challenges from the sponsor's perspective
Valentina Geisseler-Homann
F. Hoffmann-La Roche Ltd, Switzerland
Senior Clinical Trial Regulatory Lead